SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-167916
Filing Date
2023-06-15
Accepted
2023-06-15 16:17:03
Documents
12
Period of Report
2023-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d455998d8k.htm   iXBRL 8-K 40422
  Complete submission text file 0001193125-23-167916.txt   163268

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kdny-20230609.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20230609_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20230609_pre.xml EX-101.PRE 11266
6 EXTRACTED XBRL INSTANCE DOCUMENT d455998d8k_htm.xml XML 3361
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 231017563
SIC: 2834 Pharmaceutical Preparations